EXEL

AS OF

Nov 14, 12:52 PM (EDT)

Price

$42.55

Change

+$0.20 (+0.47%)

Capitalization

11.35B

88 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

EXEL

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Exelixis (EXEL) Earnings Date & Reports

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

EXEL is expected to report earnings to fall 16.77% to 64 cents per share on February 10

Q4'25

Est.

$0.65

Q3'25

Beat

by $0.09

Q2'25

Beat

by $0.11

Q1'25

Beat

by $0.25

Q4'24

Beat

by $0.16

The last earnings report on November 04 showed earnings per share of 77 cents, beating the estimate of 68 cents. With 281.21K shares outstanding, the current market capitalization sits at 11.35B.

View a ticker or compare two or three

Compare

EXEL

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. EXEL showed earnings on November 04, 2025. You can read more about the earnings report here.

View AI-Driven Trading for EXEL

A.I. Advisor

published General Information

General Information

a developer of small molecule therapies for the treatment of cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

1851 Harbor Bay Parkway

Phone

+1 650 837-7000

Employees

1310

Web

https://www.exelixis.com